WuXi PharmaTech Schedules Second-Quarter 2014 Earnings Release

SHANGHAI, July 22, 2014 /PRNewswire/ — WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the second quarter of 2014 after the New York Stock Exchange closes on Wednesday, August 13, 2014 (which will be Thursday morning, August 14, 2014 Shanghai time). The earnings release will be available on the investor relations section of the Company’s website at http://www.wuxiapptec.com . Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) / 8:00 pm (Beijing/Shanghai/Hong Kong) on Thursday, August 14, 2014, to discuss the second-quarter 2014 financial results and recent business activities. The conference call may be accessed by calling: Mainland China4001 200 539Hong Kong800 905 927Singapore800 616 3222United Kingdom0800 015 9725United States1855 298 3404United States — New York (toll)+1 631 5142 526Other countries (toll)+65 6823 2299Conference ID7388753 A telephone replay will be available two hours after the call’s completion at: Mainland China4001 842 240Hong Kong800 966 697Singapore800 616 2127United Kingdom0800 169 7301United States1866 846 0868Conference ID7388753 A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech’s website at http://www.wuxiapptec.com. About WuXi PharmaTechWuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech’s services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please contact: Ronald AldridgeDirector of Investor RelationsWuXi PharmaTech (Cayman) Inc.Tel: +1-201-585-2048 Email: Ron_Aldridge@wuxiapptec.com Web: http://www.wuxiapptec.com